» Articles » PMID: 31998058

Gender-Specific Effect of 5-HT and 5-HIAA on Threshold Level of Behavioral Symptoms and Sex-Bias in Prevalence of Autism Spectrum Disorder

Overview
Journal Front Neurosci
Date 2020 Jan 31
PMID 31998058
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Platelet hyperserotonemia in a subset of Autism Spectrum Disorder (ASD) probands, efficacy of selective serotonin reuptake inhibitors (SSRIs) in reducing behavioral deficits and gender-bias in normal serotonin (5-hydroxy tryptamine or 5-HT) synthesis suggest disruption in stringent regulation of serotonin metabolism in ASD. Therefore, we investigated the changes in 5-HT and 5-hydroxy indole acetic acid (5-HIAA) in ASD probands to assess its effect on the behavior of male and female probands. ASD cases ( = 215) were examined using childhood autism rating scale (CARS). Platelet 5-HT (104 cases and 26 controls) and platelet/plasma 5-HIAA (73 cases and 17 controls) were estimated using high performance liquid chromatography coupled with electrochemical detector (HPLC-ECD). In male probands, we observed increase in platelet 5-HT content in association with increase in the score for adaptive responses and increase in platelet 5-HIAA levels with concomitant decline in the score for intellectual response. Age did not influence the neurochemical parameters, but imitation, listening responses and nonverbal communication scores decreased with age. Conversely in female probands, plasma 5-HIAA level significantly attenuated with age, when platelet 5-HT content remained unchanged. Interestingly, platelet/plasma 5-HT and plasma 5-HIAA were higher in female controls. Female probands displayed severe autism-associated behaviors. Overall results indicate gender-bias in 5-HT and 5-HIAA regulation, which probably increases the threshold level of ASD phenotypes in the females, thereby affecting ASD prevalence in a sex-specific manner.

Citing Articles

Tryptophan metabolite atlas uncovers organ, age, and sex-specific variations.

Perez-Castro L, Nawas A, Kilgore J, Garcia R, Lafita-Navarro M, Acosta P bioRxiv. 2025; .

PMID: 39763948 PMC: 11703250. DOI: 10.1101/2024.12.23.630041.


A Systematic Review on Autism and Hyperserotonemia: State-of-the-Art, Limitations, and Future Directions.

Esposito D, Cruciani G, Zaccaro L, di Carlo E, Spitoni G, Manti F Brain Sci. 2024; 14(5).

PMID: 38790459 PMC: 11119126. DOI: 10.3390/brainsci14050481.


Methylation of serotonin regulating genes in cord blood cells: association with maternal metabolic parameters and correlation with methylation in peripheral blood cells during childhood and adolescence.

Beceheli I, Horvaticek M, Peric M, Nikolic B, Holuka C, Klasic M Clin Epigenetics. 2024; 16(1):4.

PMID: 38172913 PMC: 10765867. DOI: 10.1186/s13148-023-01610-w.


Sex Differences in Tryptophan Metabolism: A Systematic Review Focused on Neuropsychiatric Disorders.

Pais M, Martins J, Castelo-Branco M, Goncalves J Int J Mol Sci. 2023; 24(6).

PMID: 36983084 PMC: 10057939. DOI: 10.3390/ijms24066010.


Women's mood at high altitude. sexual dimorphism in hypoxic stress modulation by the tryptophan-melatonin axis.

Alcantara-Zapata D, Lucero N, de Gregorio N, Astudillo Cornejo P, Ibarra Villanueva C, Baltodano-Calle M Front Physiol. 2023; 13:1099276.

PMID: 36733695 PMC: 9887123. DOI: 10.3389/fphys.2022.1099276.


References
1.
McDougle C, Naylor S, Cohen D, Aghajanian G, Heninger G, Price L . Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry. 1996; 53(11):993-1000. DOI: 10.1001/archpsyc.1996.01830110029004. View

2.
Dalla C, Pitychoutis P, Kokras N, Papadopoulou-Daifoti Z . Sex differences in animal models of depression and antidepressant response. Basic Clin Pharmacol Toxicol. 2010; 106(3):226-33. DOI: 10.1111/j.1742-7843.2009.00516.x. View

3.
Aman M, Lam K, Van Bourgondien M . Medication patterns in patients with autism: temporal, regional, and demographic influences. J Child Adolesc Psychopharmacol. 2005; 15(1):116-26. DOI: 10.1089/cap.2005.15.116. View

4.
Pagan C, Delorme R, Callebert J, Goubran-Botros H, Amsellem F, Drouot X . The serotonin-N-acetylserotonin-melatonin pathway as a biomarker for autism spectrum disorders. Transl Psychiatry. 2014; 4:e479. PMC: 4259991. DOI: 10.1038/tp.2014.120. View

5.
Leboyer M, Philippe A, Bouvard M, Guilloud-Bataille M, Bondoux D, Tabuteau F . Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives. Biol Psychiatry. 1999; 45(2):158-63. DOI: 10.1016/s0006-3223(97)00532-5. View